SCHEMBL9746335

SCHEMBL9746335

NCC(CN)(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.52
SLC6A2 P23975 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
HIF1A Q16665 1/20 0.52
LOXL2 Q9Y4K0 2/20 0.50
HTR2A P28223 2/20 0.46
CYP2A6 P11509 1/20 0.46
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KIF11 P52732 1/20 0.44
CYP2D6 P10635 2/20 0.43
CYP3A4 P08684 1/20 0.43
PRMT1 Q99873 1/20 0.43
LMNA P02545 1/20 0.43
MAOA P21397 3/20 0.42
MAOB P27338 3/20 0.42
CALM1 P0DP23 1/20 0.41
FDPS P14324 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21879997 0.95 TAAR1 (0.52) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2
Hydrochloric Acid SCHEMBL5091679 0.92 TAAR1 (0.50) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2
Iodide SCHEMBL5087566 0.92 TAAR1 (0.50) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2
Bromide SCHEMBL5085121 0.92 TAAR1 (0.50) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2
SCHEMBL11843995 0.83 SLC6A2 (0.55) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2
Hydrochloric Acid SCHEMBL5085043 0.78 TAAR1 (0.46) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2
Iodide SCHEMBL5092958 0.78 TAAR1 (0.46) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2
Bromide SCHEMBL5091825 0.78 TAAR1 (0.46) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2
SCHEMBL29342 0.77 TAAR1 (0.56) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2
SCHEMBL15233939 0.77 TAAR1 (0.50) TAAR1SLC6A2SMN1; SMN2HIF1ALOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5100877-A Chemotherapy, anticancer agents, improved water solubility, side effect reduction KURARAY CO., LTD. (JP) 1992-03-31 US disclosed
US-4948784-A ANTICARCINOGENIC AND-TUMOR AGENTS; WATER-SOLUBEL MACROMOLICULAR COMPLEXES; SIDE EFFECT REDUCTION KURARAY COMPANY, LTD. (JP) 1990-08-14 US disclosed
EP-0307827-A2 Novel macromolecular complexes, process for producing same and medicinal use of such complexes KURARAY CO., LTD. (JP) 1989-03-22 EP disclosed
EP-0270682-A1 NOVEL COMPLEXES, PROCESS FOR THEIR PREPARATION, AND MEDICINAL USE OF THEM KURARAY CO., LTD. (JP) 1988-06-15 EP disclosed